Skip to content

OS Therapies OSTX Stock Issued During Period Valueof Common Stockfor Patent License

Stock Issued During Period Valueof Common Stockfor Patent License at other companies

Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$1.32M
CorMedix logo
CorMedixCRMD
$750
Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$2.92M+428%
Diversified Energy
 logo
Diversified Energy DEC
$28M
Inogen logo
InogenINGN
$27.21M
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$312.83K+5.7%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:StockIssuedDuringPeriodValueofCommonStockforPatentLicense.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's stock issued during period valueof common stockfor patent license.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's stock issued during period valueof common stockfor patent license?
OS Therapies (OSTX) reported stock issued during period valueof common stockfor patent license of $1.6M in Q4 2025.
What does stock issued during period valueof common stockfor patent license mean?
The fair market value of common stock issued as consideration for the acquisition of intellectual property or patent rights. This metric highlights the use of equity as a non-cash currency to secure essential technology assets.